[Physiopathology, clinical features and therapy of thrombocytopenia].
Gugliotta
L
L
Vianelli
N
N
Catani
L
L
Belmonte
M M
MM
Gianni
L
L
Cascione
M L
ML
Tura
S
S
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000906:Antibodies / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D001792:Blood Platelets / Q000276:immunology; D003131:Combined Modality Therapy; D003613:Danazol / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008264:Macrophages / Q000502:physiology; D010587:Phagocytosis; D011696:Purpura, Thrombocytopenic / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D013156:Splenectomy
D000305:Adrenal Cortex Hormones; D000906:Antibodies; D007166:Immunosuppressive Agents; D003613:Danazol
Aspetti di fisiopatologia, clinica e terapia delle piastrinopenie.